Zvi Zemishlany

Zvi Zemishlany

Professor of Psychiatry, WPA Board Member, Representative of Zone 8 (Israel)

A professor of psychiatry at the Tel Aviv University.

He received his medical degree from Hebrew University and Hadassah Medical School in 1973 and and made his specialist education at Tel Aviv University in 1980.

Previous member of the Operational Committee of Scientific Publications. Currently WPA Zone 8 Representative, President of a binational association of mental health professionals aimed at overcoming the trauma of the Second World War experiences. He is also a member of Society Biological Psychiatry United States of America (correspondent), Israel Society Forensic Psychiatry (associate), Association European Psychiatrists (associate), Society Biological Psychiatry Israel (associate), Israel Psychiatric Association (associate; president 2003-2006), Israel Medical Association (associate).

His areas of interest include sexual medicine, forensic psychiatry, mental health services, schizophrenia, biological psychiatry, ADHD, suicide.

SYMPOSIUM SL5: PSYCHIATRY AND PRIMARY CARE

Lambda Hall

CHAIR Zvi Zemishlany (Israel) CO-CHAIR Elmars Rancans (Latvia) SPEAKER THEMES Elmārs Rancāns, Jelena Vrublevska, Rolands Ivanovs, Anda Kivite (Latvia): Depression in the Primary Care: Findings from the National Research Programme BIOMEDICINA 2014-2017. Zvi Zemishlany (Israel): Psychiatry and Primary Care in Southern Europe. Jyrki Korkeila (Finland): Psychiatry and Primary Care in Northern Europe. Edmond Hsin-tung Pi (USA): Psychiatry and Primary […]

Symposium
READ MORE

WORKSHOP WE6: THE IMPACT OF PSYCHIATRIC DISORDERS AND MEDICATIONS ON SEXUAL DYSFUNCTION

Epsilon Hall

CHAIR Zvi Zemishlany (Israel) CO-CHAIR Edmond Hsin-tung Pi (USA) SPEAKER Zvi Zemishlany (Israel) Sexual Dysfunction is prevalent among psychiatric patients and may be related to both the psychopathology and the pharmacotherapy. For instance, sexual dysfunction has been reported in as many as 30-60% of patients with schizophrenia treated with antipsychotic medications, up to 78% of […]

Workshop
READ MORE